Clearmind Medicine Inc.

NasdaqCM:CMND Stock Report

Market Cap: US$5.4m

Clearmind Medicine Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CMND?
Owner TypeNumber of SharesOwnership Percentage
Public Companies13,9540.344%
Individual Insiders38,9270.96%
Institutions366,7449.04%
Hedge Funds790,69319.5%
General Public2,846,01770.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 567.8%.


Top Shareholders

Top 14 shareholders own 29.84% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.1%
Iroquois Capital Management, LLC
451,685US$600.7k0%24.35%
8.36%
Gotham Asset Management, LLC
339,008US$450.9k0%no data
4.21%
AdvisorShares Investments, LLC
170,641US$227.0k32.7%0.04%
3.48%
UBS Asset Management AG
141,337US$188.0k0%no data
0.96%
Richard Abbe
38,812US$51.6k0%no data
0.49%
Cornerstone Wealth Group, LLC
20,000US$26.6k0%no data
0.44%
Citadel Advisors LLC
17,729US$23.6k0%no data
0.31%
Hudson River Trading LLC, Asset Management Arm
12,756US$17.0k0%no data
0.19%
SciSparc Ltd.
7,692US$10.2k0%no data
0.15%
Xylo Technologies Ltd
6,262US$8.3k0%no data
0.082%
Intergemel Provident Funds and Pension Ltd.
3,333US$4.4k0%no data
0.014%
RBC Dominion Securities Inc., Asset Management Arm
569US$756.90%no data
0.0093%
National Bank Investments Inc.
379US$503.90%no data
0.0028%
Oz Adler
115US$153.20%no data